Short answer: No. Modafinil should not be used during pregnancy or breastfeeding.
This post exists because the question comes up regularly and deserves a clear, unambiguous answer supported by the evidence.
Pregnancy: Modafinil is classified as Pregnancy Category C (US), meaning animal studies show adverse effects on the fetus and there are no adequate and well-controlled studies in humans. The risk-benefit analysis for most women overwhelmingly favours stopping modafinil during pregnancy.
Hormonal contraception interaction: This is critically important and often not mentioned. Modafinil is a CYP3A4 inducer and significantly reduces the effectiveness of hormonal contraceptives (the pill, patch, ring, implant). This interaction can lead to unintended pregnancy. If you are taking modafinil and using hormonal contraception, use a barrier method as well.
Breastfeeding: Modafinil is excreted in breast milk. Its effects on nursing infants are not well-studied. The conservative and appropriate recommendation is not to use it while breastfeeding.
If you need wakefulness support during pregnancy or postpartum: Discuss with your OB/GYN or midwife. There are safer approaches.
Is the interaction specific to estrogen-based contraceptives? Does it affect progestin-only pills equally?
The interaction primarily affects estrogen metabolism via CYP3A4. Progestin-only pills may also be affected as some progestins are also CYP3A4 substrates, but the evidence is less clear. Barrier methods as backup are recommended regardless of contraceptive type.
The hormonal contraceptive interaction is the most practically important point here and is criminally undermentioned in generic modafinil discussions. Anyone using the pill and modafinil and relying on the pill for contraception should know this immediately.
This should be in every modafinil onboarding guide. I had no idea about the contraceptive interaction until I stumbled upon it by accident. Manufacturers and vendors should disclose this more prominently.
The recommendation to continue barrier methods for one month after stopping modafinil (due to enzyme induction persistence) is also worth mentioning.
To be precise about the mechanism: modafinil induces CYP3A4, which increases the rate at which ethinyl estradiol and progestins are metabolised. The effective hormone levels can drop by 30–50%, substantially reducing contraceptive effectiveness.
Non-hormonal IUDs (copper IUD) are completely unaffected by modafinil’s enzyme effects. Worth mentioning as an option for those who want highly effective contraception without this interaction concern.